WEIGHT LOSS
Clinical trials for WEIGHT LOSS explained in plain language.
Never miss a new study
Get alerted when new WEIGHT LOSS trials appear
Sign up with your email to follow new studies for WEIGHT LOSS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Weight loss revolution: noom teams up with GLP-1 drugs in massive new study
Disease control Not yet recruitingThis study will test if combining GLP-1 medications (like semaglutide and tirzepatide) with Noom's digital health program helps people with obesity lose weight and improve health markers like blood sugar and cholesterol. About 2,310 adults will be followed for 24 months. The goal…
Matched conditions: WEIGHT LOSS
Sponsor: Noom Inc. • Aim: Disease control
Last updated May 26, 2026 06:57 UTC
-
Easier diet tracking may help you lose weight just as well
Disease control Not yet recruitingThis study tests whether tracking only high-calorie, low-nutrition foods (simplified approach) works as well as tracking all foods and calories for weight loss. About 328 adults with overweight or obesity will use a digital program for 12 months. The goal is to see if the simpler…
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New Stomach-Stitching procedure tested for weight loss in asia
Disease control Not yet recruitingThis study will test if a procedure called endoscopic sleeve gastroplasty (ESG) is safe and works well for weight loss in Asian adults with obesity. The procedure uses a special stitching tool to make the stomach smaller. About 136 people will take part, and the main goal is to s…
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
New study tests if lifestyle changes can replace weight-loss shots
Disease control Not yet recruitingThis study tests a 10-week behavioral program to help people maintain weight loss after stopping GLP-1 or other anti-obesity medications. About 64 adults who lost at least 15% of their body weight on these drugs will be randomly assigned to extra support like tailored meals, gym …
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Balloon in the belly: new hope for weight loss without surgery?
Disease control Not yet recruitingThis study tests a device called Orbera365, a balloon placed in the stomach to help people with obesity lose weight. It involves 144 adults with a BMI between 28 and 50 who have not succeeded with diet and exercise alone. The main goal is to see if the balloon helps them lose at …
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Probiotic power: could a daily dose ease tummy troubles in C-Section babies?
Prevention Not yet recruitingThis study tests whether giving a daily probiotic supplement to 180 healthy full-term babies born by C-section can help them gain weight, reduce colic and spitting up, and improve their gut health. The babies will receive either one of two probiotic blends or a placebo for the fi…
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Anabio R&D • Aim: Prevention
Last updated May 26, 2026 04:37 UTC
-
Digital diet showdown: which strategy drops the most pounds?
Symptom relief Not yet recruitingThis study aims to find the best combination of four dietary strategies—limiting high-calorie foods, eating within a set time window, increasing protein, and increasing fiber—for weight loss in adults with overweight or obesity. Over 12 weeks, 208 participants will track their we…
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated May 26, 2026 06:47 UTC
-
Weight loss showdown: pills vs. surgery – which helps pelvic floor more?
Knowledge-focused Not yet recruitingThis study looks at how two different weight loss methods—medication (GLP-1 drugs like Ozempic) and bariatric surgery—change pelvic floor symptoms like bladder leaks, urgency, and prolapse in women. About 200 women aged 18 to 89 with a BMI of 30 or higher will join. The goal is t…
Matched conditions: WEIGHT LOSS
Sponsor: Hartford HealthCare • Aim: Knowledge-focused
Last updated May 26, 2026 06:59 UTC
-
Can a popular weight loss club help breast cancer survivors? new study aims to find out
Knowledge-focused Not yet recruitingThis study is testing whether a well-known community weight loss program called TOPS can be adapted to better help breast cancer survivors lose weight. Researchers will first get feedback from survivors in focus groups, then use that feedback to run tailored TOPS classes. The goa…
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
Cash for breastfeeding: will it work?
Knowledge-focused Not yet recruitingThis study tests whether giving mothers a cash reward for breastfeeding until their child is 24 months old increases breastfeeding rates and improves health. About 1,040 mothers in Côte d'Ivoire will either receive the reward plus education or just education. Researchers will tra…
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Swiss Tropical & Public Health Institute • Aim: Knowledge-focused
Last updated May 19, 2026 11:46 UTC
-
Tiny study peers inside stomachs after bariatric surgery
Knowledge-focused Not yet recruitingThis study will use ultrasound to take pictures of the stomach in 10 patients who are having weight-loss surgery. The goal is to learn how the stomach looks before and after the operation. Patients will be asleep during the imaging, so there is little discomfort.
Matched conditions: WEIGHT LOSS
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC
-
New diabetes drug tested in liver patients
Knowledge-focused Not yet recruitingThis early-stage study looks at how the body processes HRS9531, a drug for diabetes and weight loss, in people with mild or moderate liver issues compared to those with healthy livers. About 24 adults will receive a single dose to measure drug levels and check for side effects. T…
Matched conditions: WEIGHT LOSS
Phase: PHASE1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC